Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension

Tuberkuloz ve Toraks

Volumn 54, Issue 2, 2006, Pages 177-181

  Önen, Zeynep Pinar ^a   Akkoca Yildiz, Öznur ^a   Eriş Gülbay, Banu ^a   Karabiyikoǧlu, Gülseren ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Combination treatment; Idiopathic pulmonary arterial hypertension; Inhaled iloprost; Long term treatment; Sildenafil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ILOPROST; SILDENAFIL; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; BLOOD EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG TOLERABILITY; HEART CATHETERIZATION; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC DISEASE; INHALATION; LONG TERM CARE; LUNG FUNCTION TEST; LUNG SCINTISCANNING; MALE; PULMONARY HYPERTENSION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; PIPERAZINES; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS;

EID: 33747063271     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-23.
2. Simonneau G, Nazzareno G, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (Suppl S): 5-12.
3. McLaughlin W, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension. Chest 2004; 126: 78-92.
4. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70: 580-7.
5. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blocker on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
6. Rich S, Seidlitz M, Dodin E, et al. The short term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998; 114: 787-92.
7. Wilkens H, Guth A, König J, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001; 104: 1218-22.
8. Beavo JA. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48.
9. Ahn HS, Foster M, Cable M, et al. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues. Adv Exp Med Biol 1991; 308: 191-7.
10. Bogdan M, Humbert M, Francoul J, et al. Urinary cGMP concentrations in severe primary pulmonary hypertension. Thorax 1998; 53: 1059-62.
11. Olschewski H, Ghofrani HA, Schemel T, et al. Inhaled iloprost to treat severe pulmonary hypertension. Ann Intern Med 2000; 132: 435-43.
12. Sulica R, Poon M. Current medical treatment of pulmonary arterial hypertension. Mt Sinai J Med 2004; 71: 103-14.
13. Ogata M, Ohe M, Shirato K, et al. Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension. Jpn Circ J 1993; 57: 63-9.
14. Bharani A, Mathew V, Sahu A, et al. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Indian Heart J 2003; 55: 55-9.
15. Ghofrani HA, Rose F, Schermuly RT, et al. Oral sildenafil as a long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 2003; 42: 158-64.
16. Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafll and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136: 515-22.
17. Miyamoto S, Nagaya H, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-92.
18. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assesment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (Suppl S): 40-47.